ArticleAlimentary pharmacology & therapeutics2021

Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.

Christopher A Lamb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.